Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

psoriatic

Response to: ‘Correspondence to ‘Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression’’ by Wang and Ma
Abdulla Watad, Charlie Bridgewood, Dennis G McGonagle

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-219047; DOI: 10.1136/annrheumdis-2020-219047
Correspondence to ‘Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression’
Li-Tzu Wang, Kevin Sheng-Kai Ma

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-218995; DOI: 10.1136/annrheumdis-2020-218995
Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’
Lara Fallon, Thomas V Jones

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218573; DOI: 10.1136/annrheumdis-2020-218573
Response to: ‘Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Fallon et al
Xenofon Baraliakos, Laure Gossec, Iain McInnes, Andreas Kerschbaumer, Maarten de Wit, Maxime Dougados, Jette Primdahl, Désirée van der Heijde, Josef S Smolen

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218676; DOI: 10.1136/annrheumdis-2020-218676
Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study’
Young Ho Lee

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218856; DOI: 10.1136/annrheumdis-2020-218856
Response to: ‘Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study’ by Lee
Jiangwei Xia, Lin Xu, Ke-Qi Liu, Zhi-Min Ying, Shu-Yang Xie, Hou-Feng Zheng

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218906; DOI: 10.1136/annrheumdis-2020-218906
Response to: ‘Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al’ by Huang et al
Adrian Ciurea, Raphael Micheroli

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218832; DOI: 10.1136/annrheumdis-2020-218832
Response to: ‘Comment on: ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Gossec et al’ by Wei et al
Laure Gossec, Xenofon Baraliakos, Iain McInnes, Andreas Kerschbaumer, Maarten de Wit, Maxime Dougados, Jette Primdahl, Désirée van der Heijde, Josef S Smolen

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218456; DOI: 10.1136/annrheumdis-2020-218456

Pages